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Previewseosinophils might selectively impact
worm fitness during chronic infection. It
will be helpful to recapitulate similar anal-
ysis of eosinophil-deficient mice in patho-
physiological contexts such as helminth
infection.
Recent work establishes a link between
nutrient intake and eosinophil homeo-
stasis (Nussbaum et al., 2013). Diet is
an important factor regulating intestinal
health, which in turn is thought to impact
autoimmune and inflammatory disease
susceptibility. The role of eosinophils
in diet-related intestinal dysbiosis is un-
clear. It will be fascinating to learn how
eosinophil function is directly affected
by changes in availability of dietary me-
tabolites such as in low-fiber, high-fat,
restricted nutrient diets. The link between
micronutrient deficiency and type 2barrier immunity was recently highlighted
(Spencer et al., 2014). The role of eosino-
phils in adapting dynamically to dietary
changes and microbial presence or
absence in the gut clearly could help
elucidate mechanisms driving autoimmu-
nity and inflammatory diseases, as well as
infection and immunity in malnourished
regions.
REFERENCES
Chu, V.T., Beller, A., Rausch, S., Strandmark, J.,
Za¨nker, M., Arbach, O., Kruglov, A., and Berek,
C. (2014). Immunity 40, this issue, 582–593.
Chu, V.T., Fro¨hlich, A., Steinhauser, G., Scheel, T.,
Roch, T., Fillatreau, S., Lee, J.J., Lo¨hning, M., and
Berek, C. (2011). Nat. Immunol. 12, 151–159.
Fagarasan, S., Kawamoto, S., Kanagawa, O., and
Suzuki, K. (2010). Annu. Rev. Immunol. 28,
243–273.ImmunityHe, B., Xu, W., Santini, P.A., Polydorides, A.D.,
Chiu, A., Estrella, J., Shan, M., Chadburn, A., Villa-
nacci, V., Plebani, A., et al. (2007). Immunity 26,
812–826.
Heredia, J.E., Mukundan, L., Chen, F.M., Mueller,
A.A., Deo, R.C., Locksley, R.M., Rando, T.A., and
Chawla, A. (2013). Cell 153, 376–388.
Kato, L.M., Kawamoto, S., Maruya, M., and Fagar-
asan, S. (2014). Immunol. Cell Biol. 92, 49–56.
Nussbaum, J.C., Van Dyken, S.J., von Moltke, J.,
Cheng, L.E., Mohapatra, A., Molofsky, A.B., Thorn-
ton, E.E., Krummel, M.F., Chawla, A., Liang, H.E.,
and Locksley, R.M. (2013). Nature 502, 245–248.
Rothenberg, M.E., and Hogan, S.P. (2006). Annu.
Rev. Immunol. 24, 147–174.
Spencer, S.P., Wilhelm, C., Yang, Q., Hall, J.A.,
Bouladoux, N., Boyd, A., Nutman, T.B., Urban,
J.F., Jr., Wang, J., Ramalingam, T.R., et al.
(2014). Science 343, 432–437.
Wu, D., Molofsky, A.B., Liang, H.E., Ricardo-Gon-
zalez, R.R., Jouihan, H.A., Bando, J.K., Chawla, A.,
and Locksley, R.M. (2011). Science 332, 243–247.Microbial Learning Lessons:
SFB Educate the Immune SystemYun Kyung Lee1 and Sarkis K. Mazmanian1,*
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA
*Correspondence: sarkis@caltech.edu
http://dx.doi.org/10.1016/j.immuni.2014.04.002
Segmented filamentous bacteria (SFB) contribute to immune-system maturation. In this issue of Immunity,
Goto et al. (2014) and Le´cuyer et al. (2014) provide evidence for how SFB induce antigen-specific T helper
17 cells and promote development of adaptive immunity at discrete mucosal sites.Powerful signals from the microbiota
instruct architectural and functional fea-
tures of the mammalian immune system
(Lee and Mazmanian, 2010). Though the
human and mouse microbiota contain
several hundred species, only a handful
of microorganisms have been experimen-
tally shown to have immune-modulating
capabilities. Segmented filamentous
bacteria (SFB) are unique, compared to
other microbes, in their ability to induce
germinal center activation in Peyer’s
patches (PPs) of mice (Talham et al.,
1999), increase production of immuno-
globulin A (IgA) (Klaasen et al., 1993),
and contribute to the expansion and func-
tion of mucosal T cells (Umesaki et al.,
1999). Unlike other T helper cell subsets,T helper 17 (Th17) cells, which have
been linked to both mucosal resistance
to enteric pathogens and to autoimmunity
in mice, are acutely responsive to the mi-
crobiota and to SFB in particular. Germ-
free animals are essentially devoid of gut
Th17 cells (Ivanov et al., 2008), and inter-
est in SFBwas rekindledwhen two groups
showed that this microbe specifically
induced Th17 cells in the small intestine
of mice (Ivanov et al., 2009; Gaboriau-
Routhiau et al., 2009). Subsequent work
showed that SFB promote Th17 re-
sponses at extraintestinal locations dur-
ing autoimmune inflammation (Lee et al.,
2011; Wu et al., 2010), and although the
site of induction is unknown, a gut origin
is likely. In this issue, two papers extendunderstanding of how specific members
of the gutmicrobiota educate themucosal
immune system. Goto et al. (2014), and
Le´cuyer et al. (2014), show that SFB
induce adaptive immune responses at
specific, and unconventional, mucosal
sites, likely involving a process that re-
quires presentations of SFB antigens.
Mice and humans are born with an
immature gut-associated lymphoid tissue
(GALT) that develops simultaneously as a
complex microbiota of several hundred
bacterial species is forming after intro-
duction to gut microbes after birth. The
concurrent development of both the im-
mune system and microbiota suggests
that postnatal maturation of the host
might, in part, depend on input from gut40, April 17, 2014 ª2014 Elsevier Inc. 457
Figure 1. SFB Induce Adaptive Immune Responses at Several Mucosal Sites via Antigen Presentation
SFB are able to induce activation of germinal centers in PPs and drive formation of ILFs. IgA can be produced at these sites. In the absence of PPs and ILFs, SFB
are still able to induce adaptive immunity, presumably at tertiary lymphoid sites in the LP. This process appears to be dependent on MHCII expression for DCs to
induce Th17 cell development and for ILCs to inhibit Th17 cells.
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Previewsbacteria. Indeed, adult germ-free animals
display specific defects in both the
physical architecture of the GALT, as
well as in distinct immune cell subsets.
Furthermore, not all bacteria are similar
in their ability to induce developmental
processes in mice. Le´cuyer and col-
leagues focus on anatomical sites of
induction for IgA-secreting and Th17
cells, comparing colonization of mice
with SFB to a nonpathogenic strain of
Escherichia coli. As mentioned, PPs are
considered a major inductive site for
activation of mucosal immunity in
response to gut bacteria, although other
secondary and tertiary immune sites—
such as mesenteric lymph nodes (MLNs),
the lamina propria (LP), and isolated
lymphoid follicles (ILFs)—have also been
implicated. Le´cuyer and colleagues
confirm that colonization of mice with
SFB induces activation of germinal cen-
ters in PPs (Figure 1). Intriguingly, mice
lacking PPs were still able to support
production of IgA-secreting cells in
response to SFB, albeit in reduced
numbers compared to wild-type mice,
whereas these structures remain required
for adaptive immune responses to E. coli.
In addition to PPs, the authors reveal458 Immunity 40, April 17, 2014 ª2014 Elsevthat cryptopatch-derived ILFs are also
dispensable for the development of IgA-
secreting cells in response to SFB, sug-
gesting that perhaps the LP or transiently
induced tertiary lymphoid tissues might
also be involved in responses to this
unique microbe. Indeed, monocoloniza-
tion with SFB, but not E. coli, resulted in
the de novo development of tertiary
lymphoid tissues in the LP that are distinct
from cryptopatch-derived ILFs (which
require the transcription factor RAR-
related orphan receptor-gt [RORgt] for
their formation). Presumably, in addition
to PPs, tertiary lymphoid tissues, also
found in mice with a complex microbiota,
are the location for IgA responses in SFB
monocolonized mice, a notion further
supported by findings that MLNs or the
spleen are not required for induction of
adaptive immunity in response to SFB.
Le´cuyer and colleagues also investi-
gated the anatomical requirements for
SFB-mediated induction of Th17 cells. In
contrast to IgA, the Th17 cell response
to SFB was at least partially antigen spe-
cific. PPs and cryptopatch-derived ILFs
were fully dispensable for SFB-meditated
interleukin-17 (IL-17) production from
CD4+ T cells. However, T cells from miceier Inc.that are unable to form PPs, ILFs, and
de novo tertiary lymphoid structures did
not express IL-17 in response to SFB
antigens, further suggesting these tran-
sient sites as being important for immune
regulation by SFB. Nonspecific Th17
cells did appear in the MLNs of SFB
monocolonized mice without organized
mucosal lymphoid tissues, demonstrating
that this microbe can elicit proinflam-
matory T cells that might impact immunity
in systemic compartments. It is inter-
esting to speculate whether these non-
antigen-specific Th17 might be involved
in extraintestinal autoimmune responses
driven by SFB in animal models of
multiple sclerosis and rheumatoid arthritis
(Lee et al., 2011; Wu et al., 2010).
The notion that commensal bacteria
can induce antigen-specific adaptive
immunity in the gut is intriguing, and SFB
offer a tool for investigating this concept.
Cytokine signaling, partially regulated
by the microbiota, likely plays a critical
role in Th17 cell induction (Ivanov et al.,
2009); however, whether other pathways
including cell contact-dependent mecha-
nisms are required has remained un-
known. Goto and colleagues show that
major histocompatibility complex II
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antigens to T cells is critical for the induc-
tion of mucosal Th17 cells (Figure 1).
Similar to Le´cuyer and colleagues, these
authors show that gut Th17 cell re-
sponses can be both specific for SFB,
or not, but that SFB-specific Th17 cell
induction requires SFB. This suggests
a critical role for antigen presentation.
Indeed, SFB-specific Th17 cells are
greatly reduced in the GALT of MHCII-
deficient mice, whereas nonspecific
Th17 cell proportions are unchanged in
these animals, suggesting that cell
contact is required for distinguishing be-
tween the development of populations
with differing antigenic or antigen speci-
ficities. Goto and colleagues further
demonstrate that restricting MHC dele-
tion to intestinal dendritic cells (DCs)
abrogates SFB-specific Th17 cell devel-
opment, suggesting that CD11c+ DCs
process and present SFB antigens to
CD4+ T cells to initiate this process. The
cytokine environment is important for
both specific and nonspecific Th17 cells
but ostensibly is not sufficient for the
development of SFB-specific Th17 cells
in the murine small intestinal LP. Though
this study indicates that SFB-induced
Th17 cells recognize proteins from SFB,
the identity and characteristics of the an-
tigens remain undefined. Nevertheless, it
appears that most Th17 cells that are
induced by SFB recognize antigens from
this organism, in a response that is poly-
clonal and thus suggesting that numerous
SFB antigens might be presented by
MHCII on DCs.
In accord with the companion study,
Goto and colleagues show that PPs and
ILFs are dispensable for SFB-induced
Th17 cells, further suggesting that the LP
might be a site of induction for IL-17-
producing CD4+ T cells in the GALT. The
authors propose a model whereby DCs
in the small intestine acquire and present
SFB antigens during the local priming of
CD4+ T cells. They further investigate
other cell types that might be involvedin antigen presentation, initially ruling out
intestinal epithelial cells (IECs) that are
known to express MHCII. Intriguingly,
they identify MHCII expression on Lin
RORgt+ innate lymphoid cells (ILCs) and
show that deletion of MHCII specifically
in group 3 innate lymphoid cells (ILC3)
results in increased proportions and
numbers of small intestinal Th17 cells,
even in the absence of SFB. Colonization
of ILC3DMHCII mice with SFB leads to a
further enhancement of Th17 cells, with
these cells having features of antigen
specificity for SFB. Thus, MHCII expres-
sion on ILC3 cells seems to restrain
Th17 cell development to both diverse
gut bacteria and SFB. The dynamic rela-
tionship between DCs and ILCs, and the
complex environments where these cells
interact (e.g., PPs, ILFs, tertiary lymphoid
structures) to mediate the potent effects
of the microbiota are undefined but
likely represent fascinating features of
immune orchestration by gut bacteria.
These two studies expand our under-
standing for how a specific member of
the mammalian microbiota regulates
adaptive immune responses in the gut.
Research into mechanistic aspects of
host-microbial interactions with the im-
mune system represents an exciting
approach to expand our appreciation
of this intricate and highly evolved rela-
tionship. SFB are a leading example
of a microbe that has forged a deep
evolutionary connection with mammals,
having the unique adaptation to promote
specific aspects of host immune develop-
ment. It will be important to determine
whether there are specific SFB antigens
that drive IgA production and Th17 cells
and/or how SFB create a cytokine envi-
ronment along with antigen presentation
to elicit their potent immune-modulating
capabilities. The milieu SFB create also
relates to the site of cell induction, which
will require further exploration into the
biology of tertiary immune structures,
and cellular and molecular interactions
between DCs, ILCs, and other cell types.ImmunityOf critical importance will be the dis-
covery of SFB molecules that activate
an immunomodulatory process, perhaps
signaling via pattern recognition recep-
tors, G-protein-coupled receptors, or
other pathways that ‘‘educate’’ DCs to
present SFB antigens in a manner that
enhances specific immune responses in
defined anatomical locations. Discov-
ering how commensal microbes promote
development of specific features and
functions within our immune system
might teach us important lessons in how
to harness the microbiota for medical
benefit.
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